Companies similar to BEAM THERAPEUTICS INC (BEAM)
Health Care · NASDAQ
BEAM THERAPEUTICS INC (BEAM)'s closest peers include CRISPR THERAPEUTICS AG (CRSP), EDITAS MEDICINE INC (EDIT) and INTELLIA THERAPEUTICS INC (NTLA). This peer set is drawn from BEAM's enriched company profile and is informational only — not financial advice.
Similar companies
-
CRISPR THERAPEUTICS AGCRSPHealth Care
CRISPR Therapeutics develops gene-editing medicines using CRISPR/Cas9 technology, with the first approved CRISPR therapy (CASGEVY) for sickle cell disease and…
$48.57 (as of 2026-07-16) · market cap $4.7B
-
EDITAS MEDICINE INCEDITHealth Care
A pioneering CRISPR gene editing company developing in vivo therapies for genetic diseases, with lead candidate EDIT-401 targeting hyperlipidemia through LDL…
$2.88 (as of 2026-07-16) · market cap $435M
-
INTELLIA THERAPEUTICS INCNTLAHealth Care
CRISPR-based genome editing company developing in vivo therapies for rare genetic diseases including hereditary angioedema and ATTR amyloidosis.
$11.86 (as of 2026-07-16) · market cap $1.6B
Not quite? Describe exactly what you want →
Peers are drawn from BEAM's enriched profile (the same similarity signal the chat uses for "companies like BEAM"). See the full profile: BEAM THERAPEUTICS INC (BEAM).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.